University of Colorado influenza chip licensed by Quidel

The University of Colorado announced it has entered into an exclusive license agreement with Quidel Corp. to market Flu Chip and MChip diagnostic technologies developed by CU-Boulder researchers in collaboration with the Centers for Disease Control and Prevention in Atlanta. The Flu Chip and MChip can be used to determine the genetic makeup of specific influenza strains from patient samples within hours. Current methods take about four days.